Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Adult Stem Cells01:33

Adult Stem Cells

33.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells00:58

Embryonic Stem Cells

32.7K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.7K
Embryonic Stem Cells00:57

Embryonic Stem Cells

5.3K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.3K
Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NAD+ metabolic collapse and arrest of epithelial development in Hirschsprung disease.

World journal of pediatric surgery·2026
Same author

Embryonic Gut Explant Model for Enteric Neural Crest Cells Migration.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Embryonic Gut Enteric Neural Crest Cells Derived Neurospheres.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Short-chain fructooligosaccharides protect against intestinal injury in NEC by restoring AKT/GSK-3β signaling.

Journal of pediatric surgery·2026
Same author

Molecular and Chromatin Accessibility Programs Underlying Epithelial Injury and Impaired Regeneration in Neonatal Necrotizing Enterocolitis.

Cellular and molecular gastroenterology and hepatology·2026
Same author

Remote ischemic conditioning in necrotizing enterocolitis: an extended phase I safety study.

Pediatric surgery international·2025

Related Experiment Video

Updated: Feb 16, 2026

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis
08:42

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

8.2K

Stem cell therapy in necrotizing enterocolitis: Current state and future directions.

Natalie A Drucker1, Christopher J McCulloh2, Bo Li3

  • 1Department of Surgery, Section of Pediatric Surgery, Indiana University School of Medicine, Riley Hospital for Children at IU Health, 705 Riley Hospital Dr. RI 2500, Indianapolis, Indiana 46202.

Seminars in Pediatric Surgery
|December 26, 2017
PubMed
Summary

Mesenchymal stem cells show promise for treating necrotizing enterocolitis. Acellular components like exosomes may also offer therapeutic benefits, with ongoing research exploring their mechanisms.

Keywords:
IntestineIschemiaNecrotizing enterocolitisNeonatalPrematureStem cell therapy

More Related Videos

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis
09:11

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

Published on: June 8, 2022

2.8K
A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

4.1K

Related Experiment Videos

Last Updated: Feb 16, 2026

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis
08:42

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

8.2K
In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis
09:11

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

Published on: June 8, 2022

2.8K
A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

4.1K

Area of Science:

  • Regenerative medicine
  • Gastroenterology
  • Neonatal care

Background:

  • Necrotizing enterocolitis (NEC) is a severe intestinal disease in premature infants.
  • Current treatments for NEC have limitations.
  • Stem cell therapy presents a novel therapeutic avenue for NEC.

Purpose of the Study:

  • To evaluate the potential of mesenchymal stem cells (MSCs) as a treatment for NEC.
  • To explore the efficacy of acellular components, such as exosomes, derived from MSCs for NEC treatment.
  • To investigate the underlying mechanisms of MSC-mediated therapeutic effects in NEC.

Main Methods:

  • Review of current literature on stem cell therapy for NEC.
  • Analysis of preclinical and clinical studies investigating MSCs and their derivatives.
  • Examination of proposed mechanisms of action for MSCs and exosomes in NEC.

Main Results:

  • Mesenchymal stem cells are identified as a highly promising cell-based therapy for NEC due to their practicality and efficacy.
  • Acellular components, including exosomes and paracrine mediators, also demonstrate significant therapeutic potential.
  • Multiple mechanisms are implicated in the beneficial effects of these stem cell-derived therapies.

Conclusions:

  • Mesenchymal stem cells and their acellular components offer a promising therapeutic strategy for necrotizing enterocolitis.
  • Further research is essential to fully understand and optimize the use of these therapies.
  • Targeting the mechanisms of action will be crucial for advancing stem cell-based treatments for NEC.